期刊文献+

阿托伐他汀对慢性心衰早期肾损害的短期疗效 被引量:3

The Protective Effect of Atorvastatin on Early Impairment of Renal Function in Chronic Heart Failure
下载PDF
导出
摘要 目的观察阿托伐他汀对慢性心衰患者尿微量白蛋白(MAU)和高敏C反应蛋白(hsCRP)的影响,为防治慢性心衰早期肾损害提供临床依据。方法将120例慢性心衰患者随机分为对照组(n=60)和他汀组(n=60),对照组给予常规抗心衰药物治疗,他汀组在常规治疗基础上加用阿托伐他汀20mg/d;观察2组患者治疗3个月前后TG、TC、LDL-C、Scr、Bun、MAU、hsCRP值变化。结果 2组治疗前后以及两组治疗后比较,TG、Scr、Bun值均无显著性差异;他汀组治疗后与治疗前比较以及他汀组与对照组治疗后比较,TC、LDL-C、MAU、hsCRP值均显著降低(P<0.05);MAU、hsCRP相关性分析呈显著负相关(r=-0.58,P=0.04)。结论阿托伐他汀对慢性心衰早期肾损害有保护作用,他汀类抗炎作用是其内在机制之一。 Objectives To investigate the protective effect and possible mechanism of atorvastatin on early impairment of renal function in chronic heart failure(CHF).Methods 120 CHF patients were divided randomly into statin group(n=60)and control group (n=60).statin group received atorvastatin(20mg/d) on the basis of conventional treatment of control group.The levers of TG、 TC、LDL-C、Scr、Bun、MAU、hsCRP were detected before and after 3 months treatment.Results There were no significant differences in the levels of TG、Scr、Bun between the two groups before and after treatment. After treatment the levels of TC、 LDL-C、MAU、hsCRP in statin group were significantly lower than that of control and before treatment(P〈0.05).MAU was negatively correlated with hsCRP(r=-0.58,P=0.04).Conclusions atorvastatin can efficiently improve early impairment of renal function in CHF.The possible mechanism is anti-inflammatory of atorvastatin.
出处 《中外医疗》 2010年第13期23-24,27,共3页 China & Foreign Medical Treatment
关键词 阿托伐他汀 慢性心衰 尿微量白蛋白 C反应蛋白 Atorvastatin Chronic heart failure Microalbuminuria C-reactive protein
  • 相关文献

参考文献10

  • 1Shlipak MG,Massie BM.The clinical challenge of cardiorenal Syndrome[J].Circulation,2004,110,1514-1517.
  • 2MaisCH NM,Pezzillo KK.HMG-CoA reductase inhibitors for the prevention of n ephropathy[J].Ann Pharmacother,2004,38(2):342-345.
  • 3金争鸣,胡晓晟,陈君柱,胡申江,张芙荣.慢性心力衰竭患者早期肾损害的临床研究[J].中华内科杂志,2005,44(4):262-264. 被引量:42
  • 4Marczewski KT,Krawczy W,Ryszard,et al.Particular fraction of microprotei nuria in patients with stabile angina pectoris and without a clinical nephropat hy[J].Med Sci Monit,2000,6:93-95.
  • 5Dobre D,Nimade S,de Zeeuw D.Albuminuria in heart failureiwhat do we real ly know[J].Curr Opin CardioL2009,24(2):148- 154.
  • 6Attallah N,Yassine L,Musial J,et al.The potential role of statins in contrast nephropathy[J].Clin Nephrol,2004,62(4):273-278.
  • 7Lubitz SA,Pinney S,Wisnivesky JP,et al.Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation[J].J Heart Lung Transplant,2007,26(3):264-272.
  • 8Phquett RU,Cornish KG,Peuler JD,et al.Simvastatin normalizes autonomic neural control in experimental heart failure[J].Circulation,2003,107(19):2493-2498.
  • 9Tonelli M.The effect of statins on preservation of kidney function in patients with coronary artery disease[J].Curr Opin Cardiol,200,21(6):608-612.
  • 10Kishi T,Yamada A,Okamatsu S,et al.Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus[J].J Cardiol,2009,53(3):341-348.

二级参考文献7

  • 1Marenzi G, Lauri G, Guazzi M, et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci,2001,321:359-366.
  • 2Marczewski KT, Krawczyk W, Ryszard, et al. Particular fractions of microproteinuria in patients with stabile angina pectoris and without a clinical nephropathy. Med Sci Monit,2000,6:93-95.
  • 3Pittrow D, Wittchen HU, Bramlage P, et al. Nephropathy: an overview for daily practice. Fortschr Med Orig, 2003,121 Suppl 1:39-44.
  • 4Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin Ⅱ antagonists. Kidney Int,2000,57:1803-1817.
  • 5Russo D, Pisani A, Balletta MM, et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis, 1999,33:851-856.
  • 6Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation,2000,102:203-210.
  • 7Smilde TD, Hillege HL, Navis G, et al. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J,2004,148:165-172.

共引文献41

同被引文献15

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部